泽璟制药(688266) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥108,244,408.58, representing a year-on-year increase of 0.12%[6] - The net profit attributable to shareholders of the listed company was -¥39,499,383.01, with a basic and diluted earnings per share of -¥0.15[6] - Total operating revenue for Q1 2024 was 108,244,408.58 RMB, a slight increase from 108,110,475.27 RMB in Q1 2023, representing a growth of 0.12%[31] - Net loss for Q1 2024 was 44,630,785.90 RMB, an improvement compared to a net loss of 59,875,793.87 RMB in Q1 2023, reflecting a decrease in losses of about 25.5%[34] - Basic and diluted earnings per share for Q1 2024 were both -0.15 RMB, compared to -0.24 RMB in Q1 2023, showing an improvement in per-share losses[35] - Operating profit for Q1 2024 was CNY -31,137,088.26, an improvement from CNY -51,000,168.10 in Q1 2023[51] - Net loss for Q1 2024 was CNY -31,136,645.78, compared to a net loss of CNY -51,472,548.63 in Q1 2023, indicating a significant reduction in losses[53] Research and Development - Research and development expenses totaled ¥84,346,541.11, accounting for 77.92% of operating revenue, a decrease of 7.08 percentage points compared to the previous year[8] - Research and development expenses for Q1 2024 were 84,346,541.11 RMB, down from 91,892,329.58 RMB in Q1 2023, indicating a decrease of approximately 8.3%[32] - Research and development expenses for Q1 2024 were CNY 73,984,650.89, down from CNY 85,481,154.46 in Q1 2023, reflecting a 13.5% decrease[51] Assets and Liabilities - The company's total assets increased by 7.53% year-on-year, reaching ¥3,104,747,952.94[8] - Total assets reached RMB 3,104,747,952.94, up from RMB 2,887,206,825.31, indicating an increase of approximately 7.5%[27] - The total assets as of March 31, 2024, amounted to ¥3,141,225,650.84, an increase from ¥2,901,876,252.46 at the end of 2023, reflecting a growth of approximately 8.2%[46] - The company's total liabilities increased to 1,504,035,955.97 RMB in Q1 2024 from 1,242,369,776.94 RMB in Q1 2023, marking an increase of about 21.06%[32] - The total liabilities increased to CNY 1,449,642,076.50 in Q1 2024 from CNY 1,179,233,995.74 in Q1 2023, representing a 23% increase[51] Cash Flow - The net cash flow from operating activities was ¥89,023,867.97, significantly boosted by a ¥200 million exclusive sales promotion authorization fee received during the reporting period[12] - The net cash flow from operating activities for Q1 2024 was ¥89,023,867.97, a significant improvement compared to a net outflow of ¥30,605,429.71 in Q1 2023[38] - Total cash inflow from operating activities reached ¥310,024,749.02, up from ¥181,438,655.13 in the same period last year, representing an increase of approximately 70.9%[38] - Cash outflow from operating activities was ¥221,000,881.05, slightly higher than ¥212,044,084.84 in Q1 2023, indicating a 4.5% increase[38] - The net cash flow from investing activities was -¥315,901,464.79, worsening from -¥74,495,416.97 in Q1 2023, reflecting increased investment expenditures[41] - Cash inflow from investing activities totaled ¥117,324,826.94, down from ¥150,904,222.13 in the previous year, a decrease of about 22.2%[41] - Cash outflow from investing activities surged to ¥433,226,291.73, compared to ¥225,399,639.10 in Q1 2023, marking an increase of approximately 92.1%[41] - The net cash flow from financing activities was ¥94,612,139.70, a decrease from ¥103,158,702.59 in Q1 2023[41] - Cash inflow from financing activities was ¥349,000,000.00, up from ¥267,000,000.00 in the same quarter last year, representing a growth of about 30.7%[41] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,931[17] - The company has not reported any significant changes in shareholder relationships or agreements during the reporting period[17] Other Financial Metrics - The weighted average return on net assets was -2.45% for the reporting period[8] - Total current assets increased to RMB 2,722,994,152.50 from RMB 2,520,336,094.40, reflecting a growth of about 8%[23] - Total current liabilities increased to RMB 1,208,189,825.59 from RMB 1,135,181,236.87, which is an increase of about 6.3%[27] - Non-current assets totaled RMB 381,753,800.44, up from RMB 366,870,730.91, showing a growth of approximately 4%[26] - The company reported accounts receivable of RMB 112,023,076.65, an increase from RMB 101,139,998.16, representing a growth of about 10.5%[22] - Inventory increased to RMB 130,430,627.80 from RMB 110,852,343.86, reflecting a rise of approximately 17.6%[22] - The company did not recognize any share-based payment expenses during the reporting period, contributing to the changes in net profit[12] - The company has not disclosed any new product developments or market expansion strategies in this report[15] - Other income for Q1 2024 was 2,655,577.65 RMB, down from 6,460,560.93 RMB in Q1 2023, a decrease of about 58.8%[32] - The company experienced a decrease in cash received from investment activities, totaling $110,229,926.94 compared to $175,904,222.13 in Q1 2023[55] - The company reported a total tax payment of $16,734,592.11 for the quarter[55] - Cash paid for other operating activities was $126,080,478.08, slightly lower than $137,673,612.15 in the previous year[55] - The cash flow impact from exchange rate changes was $1,935.45, contrasting with a negative impact of -$1,891.24 in the previous year[55] - The company’s initial cash and cash equivalents balance was $1,865,094,748.53, indicating a strong liquidity position[55] - The company is implementing new accounting standards starting in 2024, which may affect financial reporting[55]